Incidence, Presentation and Risk Factors for Sodium Valproate-Associated Hyperammonemia in Neurosurgical Patients: A Prospective Observational Study (Q99357630)

From Wikidata

Jump to navigation Jump to search

scientific article published on 08 September 2020

Language	Label	Description	Also known as
English	Incidence, Presentation and Risk Factors for Sodium Valproate-Associated Hyperammonemia in Neurosurgical Patients: A Prospective Observational Study	scientific article published on 08 September 2020

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

Incidence, Presentation and Risk Factors for Sodium Valproate-Associated Hyperammonemia in Neurosurgical Patients: A Prospective Observational Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

author name string

Peter Ym Woo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

Alexander Wy Woo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

Sandy W Lam

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

Natalie Mw Ko

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

Joanna Wk Ho

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

Alberto Ch Chu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

Marco Cl Kwan

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

Yung Chan

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

Hoi-Tung Wong

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

Kwong-Yau Chan

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

publication date

8 September 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

World Neurosurgery

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Valproate-induced hyperammonemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Valproic acid-induced hyperammonemia: Incidence, clinical significance, and treatment management

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Hyperammonemia in review: pathophysiology, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Valproic acid pathway: pharmacokinetics and pharmacodynamics

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

New insights on the mechanisms of valproate-induced hyperammonemia: Inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Valproic acid-induced hyperammonemic encephalopathy - a potentially fatal adverse drug reaction

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Valproate-induced hyperammonemic encephalopathy in the presence of topiramate

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Development of an epilepsy-specific risk adjustment comorbidity index

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

A model to predict survival in patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010.

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Idiosyncratic adverse reactions to antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Asymptomatic hyperammonemia in patients receiving valproic acid

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Fatal hyperammonemic brain injury from valproic Acid exposure

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Different clinical manifestations of hyperammonemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Valproate-induced hyperammonemic encephalopathy: a brief review.

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Is 2-propyl-4-pentenoic acid, a hepatotoxic metabolite of valproate, responsible for valproate-induced hyperammonemia?

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Associations Between Risk Factors for Valproate Hepatotoxicity and Altered Valproate Metabolism

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Reversal of valproic acid-associated impairment of carnitine uptake in cultured human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Alteration of renal carnitine metabolism by anticonvulsant treatment

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

A Territorywide Prevalence Study on Blood-Borne and Enteric Viral Hepatitis in Hong Kong

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Serum concentrations of valproic acid: influence of dose and comedication

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Use of phenytoin and other anticonvulsant prophylaxis in patients with aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Differential effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Hyperammonemia: What Urea-lly Need to Know: Case Report of Severe Noncirrhotic Hyperammonemic Encephalopathy and Review of the Literature.

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

European Stroke Organisation guidelines for the management of post-stroke seizures and epilepsy

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Comparison of short-duration levetiracetam with extended-course phenytoin for seizure prophylaxis after subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Prophylactic Antiepileptics and Seizure Incidence Following Subarachnoid Hemorrhage: A Propensity Score-Matched Analysis

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Prophylactic Anticonvulsants in the Treatment of Adults with Metastatic Brain Tumors

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Three-day phenytoin prophylaxis is adequate after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Valproate-induced hyperammonemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Valproic acid-induced hyperammonemic encephalopathy with triphasic waves

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

L-carnitine was safely administered in the setting of valproate toxicity

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Carnitine as an antidote for acute valproate toxicity in children

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2020.09.027

7 January 2021

Identifiers

10.1016/J.WNEU.2020.09.027

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32916358 AND SRC:MED&resulttype=core&format=json

15 September 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q99357630&oldid=1770464618"